Cargando…

Pathway Analysis for Drug Repositioning Based on Public Database Mining

[Image: see text] Sixteen FDA-approved drugs were investigated to elucidate their mechanisms of action (MOAs) and clinical functions by pathway analysis based on retrieved drug targets interacting with or affected by the investigated drugs. Protein and gene targets and associated pathways were obtai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yongmei, Cheng, Tiejun, Wang, Yanli, Bryant, Stephen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956470/ https://www.ncbi.nlm.nih.gov/pubmed/24460210 http://dx.doi.org/10.1021/ci4005354

Ejemplares similares

Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining
por: Cheng, Tiejun, et al.
Publicado: (2011)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)

PROMISCUOUS: a database for network-based drug-repositioning
por: von Eichborn, Joachim, et al.
Publicado: (2011)

Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

HeTDR: Drug repositioning based on heterogeneous networks and text mining
por: Jin, Shuting, et al.
Publicado: (2021)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
por: Mucke, Hermann A. M.
Publicado: (2017)

Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
por: Cheng, Tiejun, et al.
Publicado: (2012)

Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer
por: Ivliev, Alexander E., et al.
Publicado: (2016)

Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge
por: Takeda, Takako, et al.
Publicado: (2017)

Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
por: Mejía-Pedroza, Raúl A., et al.
Publicado: (2018)

Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Drug repositioning prediction for psoriasis using the adverse event reporting database
por: Ko, Minoh, et al.
Publicado: (2023)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Adopting Text Mining on Rehabilitation Therapy Repositioning for Stroke
por: Meng, Guilin, et al.
Publicado: (2019)

The Text-mining based PubChem Bioassay neighboring analysis
por: Han, Lianyi, et al.
Publicado: (2010)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules
por: Cheng, Tiejun, et al.
Publicado: (2010)

PubChem BioAssay: A Decade’s Development toward Open High-Throughput Screening Data Sharing
por: Wang, Yanli, et al.
Publicado: (2017)

An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool
por: Chen, Yen-Wei, et al.
Publicado: (2022)

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
por: Zhang, Yuchen, et al.
Publicado: (2022)

Pharmacophore and 3D-QSAR Characterization of 6-Arylquinazolin-4-amines as Cdc2-like Kinase 4 (Clk4) and Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (Dyrk1A) Inhibitors
por: Pan, Yongmei, et al.
Publicado: (2013)

Computational drug repositioning using meta-path-based semantic network analysis
por: Tian, Zhen, et al.
Publicado: (2018)

DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
por: Huang, Hui, et al.
Publicado: (2015)

Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

Mining public-source databases for structure-activity relationships
por: Wendt, Bernd, et al.
Publicado: (2010)

COVID-19: Analysis of Drug Repositioning Practice
por: Savosina, P. I., et al.
Publicado: (2021)

In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u1ubtnhpggvcjrp04uqtqh1k7k